Sankom Pharma Private Limited
About Sankom Pharma Private Limited
Data last updated:
Sankom Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 07 March 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2019PTC347024. Its GSTIN is 07ABBCS7131H1ZF (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sandeep Yadav and Komal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S/O Sh Sunil Kumar House Near Pole No 29 Quazi Pur, New Delhi, Delhi, India – 110073.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.32 Lakh, a growth of 18% compared to the previous year. For the same year it recorded a net loss of ₹76,494 (net margin -23%) and EBITDA of -₹76,494 (EBITDA margin -23%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 16% over five years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressS/O Sh Sunil Kumar House Near Pole No 29 Quazi Pur, New Delhi, Delhi, India – 110073
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Sankom Pharma Private Limited
The main business activity of Sankom Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Sankom Pharma Private Limited FY 2025 filings available
Sankom Pharma Private Limited reported revenue of ₹3.32 Lakh (up 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Sankom Pharma Private Limited
Revenue rose 18% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 16%. EBITDA fell 11% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Sankom Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹76,494 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹76,494 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Sankom Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -23% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -23% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sankom Pharma are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Sankom Pharma Private Limited
Sankom Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aristro Business Private Limited | ₹3.33 Lakh (FY 2025) | •••• | •••• | -99.0% | •••• | Kalyani, West Bengal, India |
| Resper International (India) Private Limited | ₹3.33 Lakh (FY 2021) | •••• | •••• | -76.0% | •••• | Dharavi, Mumbai, Maharashtra, India |
| Srimath Consumer Merchandise Private Limited | ₹3.33 Lakh (FY 2018) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| VDP Markventures Private Limited | ₹3.33 Lakh (FY 2024) | •••• | •••• | 5.0% | •••• | Pune, Maharashtra, India |
| Bhootnath Agro Producer Company Limited | ₹3.33 Lakh (FY 2024) | •••• | •••• | -16.0% | •••• | Parbhani, Maharashtra, India |
| Sankom Pharma Private Limited this company | ₹3.32 Lakh (FY 2025) | •••• | •••• | 18.0% | •••• | New Delhi, Delhi, India |
| Carbon India Private Limited | ₹3.32 Lakh (FY 2025) | •••• | •••• | -72.0% | •••• | Bathinda, Punjab, India |
| Herbid (India) Pvt Ltd | ₹3.32 Lakh (FY 2025) | •••• | •••• | -49.0% | •••• | Haringhata, West Bengal, India |
| Linkrose Vinimay Private Limited | ₹3.32 Lakh (FY 2025) | •••• | •••• | -61.0% | •••• | Siliguri, West Bengal, India |
| Saha Mindcare and Consulting Private Limited | ₹3.32 Lakh (FY 2024) | •••• | •••• | 6.0% | •••• | Chennai, Tamil Nadu, India |
| Intro Lifestyle Products Private Limited | ₹3.32 Lakh (FY 2021) | •••• | •••• | -52.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Sankom Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Sankom Pharma Private Limited
Sankom Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sandeep Yadav | Director | 07 Mar 2019 | 7 Years 7 Months | Current |
| Komal | Director | 07 Mar 2019 | 7 Years 7 Months | Current |
Ownership and Shareholding of Sankom Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Sankom Pharma Private Limited
Sankom Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Sankom Pharma Private Limited
Employment history and EPFO contributions of people linked to Sankom Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Sankom Pharma Private Limited
Sankom Pharma Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Komal was appointed as Director on 07 Mar 2019.
Credit Ratings, Litigation & Regulatory Alerts for Sankom Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Sankom Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Sankom Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Sankom Pharma Private Limited
Sankom Pharma has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABBCS7131H1ZF | Delhi | Active | 14 Apr 2019 |
| 06ABBCS7131H1ZH | Haryana | Active | 10 May 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Sankom Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sankom Pharma Private Limited
Sankom Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 07 March 2019 (7+ years old) and is registered under CIN U24230DL2019PTC347024.
Sankom Pharma reported revenue of ₹3.32 Lakh for FY 2025 (up 18% YoY).
Sankom Pharma has 2 current directors:
- Sandeep Yadav - Director
- Komal - Director
Sankom Pharma reported a net loss of ₹76,494 (net margin -23%) and EBITDA of -₹76,494 (EBITDA margin -23%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Sankom Pharma is -20% over three years and -16% over five years. In the latest year (FY 2025) revenue rose 18%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Sankom Pharma is 07ABBCS7131H1ZF, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06ABBCS7131H1ZH (Haryana).
The CIN (Corporate Identification Number) of Sankom Pharma is U24230DL2019PTC347024. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sankom Pharma was incorporated on 07 March 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sankom Pharma by revenue are Aristro Business Private Limited, Resper International (India) Private Limited, Srimath Consumer Merchandise Private Limited, VDP Markventures Private Limited, Bhootnath Agro Producer Company Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Komal was appointed as Director on 07 Mar 2019. Sandeep Yadav was appointed as Director on 07 Mar 2019.
The registered office of Sankom Pharma is at SO Sh Sunil Kumar House Near Pole No 29 Quazi Pur, New Delhi, Delhi, India – 110073.